CN101279054A - Chinese medicinal composition for treating psoriasis - Google Patents
Chinese medicinal composition for treating psoriasis Download PDFInfo
- Publication number
- CN101279054A CN101279054A CNA2008100313636A CN200810031363A CN101279054A CN 101279054 A CN101279054 A CN 101279054A CN A2008100313636 A CNA2008100313636 A CN A2008100313636A CN 200810031363 A CN200810031363 A CN 200810031363A CN 101279054 A CN101279054 A CN 101279054A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- fructus
- root
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medical combination for treating psoriasis, which is composed of medicine for internal application and medicine for external application. The ingredients and proportion by weight of the raw materials of the medicine for internal application are as follows: 10 to 35g of smilax glabra, 5 to 20g of radix sophorae flavescentis, 9 to 20g of fruit of summer cypress, 6 to 45g of honeysuckle flower, 6 to 20g of fructus forsythiae, 5 to 15g of ledeboruiella root, 6 to 35g of bark of dictamnus dasycarpus, 9 to 35g dried rhizome of rehmannia, 9 to 55g of cogongrass rhizome, 9 to 20g of salvia miltiorrhiza, 9 to 30g of suberect spatholobus, 5 to 20g of root of Chinese angelica, 9 to 20g of black snake, 3 to 6 chilopods, 3 to 10g of scorpion, 3 to 20g of beehive, 6 to 20g of great burdock achene and 6 to 35g of tribulus terrestrisl. The ingredients and proportioning by weight of the raw materials of the medicine for external application are as follows: 9 to 35g of honeysuckle stem, 5 to 35g of beehive, 6 to 35g of bark of dictamnus dasycarpus, 5 to 35g of stiff silkworm, 3 to 15g of ephedra vulgaris, 5 to 35g of ledeboruiella root, 3 to 30g of seeds of brassica alba, 3 to 60g of arisaema erubescens schott, 3 to 60g of raw pinellia, 50 to 200g of calcium oxide and 5 to 95g of knoxia corymbosa. The traditional Chinese medical combination of the invention has good curative effect on the treatment of psoriasis and no recurrent case is found after being completely cured.
Description
Technical field
The present invention relates to the psoriatic Chinese medicine composition of a kind of treatment, especially relating to a kind of is the Chinese medicine composition of feedstock production with Chinese medicinal plant medicine and animal drugs.
Background technology
Psoriasis (psoriasis) is a stubbornness and disease kind that refractory is healed, and easily recurrence again after curing.And, adopt western medicine, side effect is big.Adopt known Chinese medicine clearing away heat and cooling blood medicine treatment, it is desirable that curative effect is also owed.The psoriatic Chinese medicine of a kind of treatment is disclosed for Chinese patent ZL200410060293.9 number, component is in parts by weight, by Zaocys 20-40, Caulis Spatholobi 20-40, Rhizoma Imperatae 20-40, Radix Rubiae 20-40, Flos Sophorae 20-40, Cortex Dictamni 20-40, Rhizoma Smilacis Glabrae 20-40, Radix Salviae Miltiorrhizae 10-20, raw pearl barley 10-20, Fructus Kochiae 10-20, Caulis Akebiae 4-8, Rhizoma Coptidis 4-8, Rhizoma Alismatis 6-12 is medicine material, makes the oral medicine of various dosage forms.According to the record of its description, this medical instrument has clearing away heat and cooling blood, dispel the wind moisturize, the effect of nourshing blood and promoting blood circulation, curative effect is quite good.But practice shows that for some patient, curative effect is still not ideal enough.
Summary of the invention
The object of the present invention is to provide a kind of good effect, the psoriatic Chinese medicine composition of the treatment of non-relapse after healing.
Technical scheme of the present invention is: it is made of oral medicine and medicine for external use, and the solvent of oral medicine and weight proportion are: Rhizoma Smilacis Glabrae 10-35g (preferred 30g), Radix Sophorae Flavescentis 5-20g (preferred 15g), Fructus Kochiae 9-20g (preferred 15g), Flos Lonicerae 6-45g (preferred 40g), Fructus Forsythiae 6-20g (preferred 15g), Radix Saposhnikoviae 5-15g (preferred 10g), Cortex Dictamni 6-35g (preferred 30g), Radix Rehmanniae 9-35g (preferred 30g) Bai Acorns root 9-55g (preferred 50g), Radix Salviae Miltiorrhizae 9-20g (preferred 15g), Caulis Spatholobi 9-30g (preferred 15g), Radix Angelicae Sinensis 5-20g (preferred 15g), Zaocys 9-20g (preferred 10g), Scolopendra 3-6 bar (preferred 2), Scorpio 3-10g (preferred 5g), Nidus Vespae 3-20g (preferred 10g), Fructus Arctii 6-20g (preferred 15g), Fructus Tribuli 6-35g (preferred 30g); Also can be according to state of an illness type, the plus-minus adjuvant drug is adjusted dosage;
Preparation method: can adopt known method to make various peroral dosage forms and take;
The consumption usage: above-mentioned consumption is crude drug consumption every day, can take at twice.
The solvent of medicine for external use and weight proportion are: Caulis Lonicerae 9-35g (preferred 30g), Nidus Vespae 5-35g (preferred 30g), Cortex Dictamni 6-35g (preferred 30g), Bombyx Batryticatus 5-35g (preferred 30g), Herba Ephedrae 3-15g (preferred 12g), Radix Saposhnikoviae 5-35g (preferred 30g), Semen Sinapis Albae 3-30g (preferred 25g), Rhizoma Arisaematis 3-60g (preferred 55g), Rhizoma Pinelliae 3-60g (preferred 55g), quicklime 50-200g (preferred 160g), Knoxia valerianoides 5-95g (preferred 90g).
Preparation method: described medicine is all ground to form fine powder, add an amount of Oleum Sesami and mix well.
Usage: be used with oral medicine, be coated with affected part 2-3 time every day.
Drug composition among the present invention, oral administration and externally is double attacks, have quite ideal clearing away heat and cooling blood, dispel the wind moisturize, the good efficacy of nourshing blood and promoting blood circulation, removing vivotoxin, good effect, be used for the treatment of example surplus the psoriasis 20, cure rate reaches 100%, and does not see recurrent cases so far.
The specific embodiment
The invention will be further described below in conjunction with an embodiment.
Present embodiment oral medicine component and weight proportion are: Rhizoma Smilacis Glabrae 30g, Radix Sophorae Flavescentis 15g, Fructus Kochiae 15g, Flos Lonicerae 40g, Fructus Forsythiae 15g, Radix Saposhnikoviae 10g, Cortex Dictamni 30g, Radix Rehmanniae 30g, Bai Acorns root 50g, Radix Salviae Miltiorrhizae 15g, Caulis Spatholobi 15g, Radix Angelicae Sinensis 15g, Zaocys 10g, 2 of Scolopendras, Scorpio 5g, Nidus Vespae 10g, Fructus Arctii 15g, Fructus Tribuli 30g.Fry in shallow oil into decoction.
Present embodiment medicine for external use component and weight proportion are: Caulis Lonicerae 30g, Nidus Vespae 30g, Cortex Dictamni 30g, Bombyx Batryticatus 30g, Herba Ephedrae 12g, Radix Saposhnikoviae 30g, Semen Sinapis Albae 25g, Rhizoma Arisaematis 55g, Rhizoma Pinelliae 55g, quicklime 160g, Knoxia valerianoides 90g.Wear into fine powder, add Oleum Sesami and mix well.
Use present embodiment product treatment psoriasis model case to introduce:
Literary composition * *, suffered from psoriasis 2 years, erythema, desquamation all over the body, the severe pruritus due to dryness, treatment is seen a doctor repeatedly by famous hospital to Changsha, fails healing.In May, 2006, use the treatment of present embodiment product through the present inventor, outer being coated with for oral administration, to the 3rd day morning, erythema just began to disappear, and other symptoms also begin to alleviate, and after 10 days, get better in the trick back, and treatment was to the 30th day, and the breast abdominal symptoms is all cured; Continued to take medicine 1 month, to consolidate curative effect; So far do not see recurrence.
Permitted * *, suffered from psoriasis 12 years, large tracts of land erythema, erythema are arranged, map shape desquamation all over the body, pruritus due to dryness is serious, to too much tame large hospital treatment repeatedly, though symptom is alleviated sometimes to some extent, fails all the time to cure.In June, 2006, use the treatment of present embodiment product through the present inventor, outer being coated with for oral administration, to the 3rd day, each symptom promptly began to alleviate, and treats continuously 3 months, and symptomatology disappears, and does not see recurrence so far.
Claims (2)
1, the psoriatic Chinese medicine composition of a kind of treatment, it is characterized in that, be made of oral medicine and medicine for external use, the raw material components of oral medicine and weight proportion are: Rhizoma Smilacis Glabrae 10-35g, Radix Sophorae Flavescentis 5-20g, Fructus Kochiae 9-20g, Flos Lonicerae 6-45g, Fructus Forsythiae 6-20g, Radix Saposhnikoviae 5-15g, Cortex Dictamni 6-35g, Radix Rehmanniae 9-35g, Bai Acorns root 9-55g, Radix Salviae Miltiorrhizae 9-20g, Caulis Spatholobi 9-30g, Radix Angelicae Sinensis 5-20g, Zaocys 9-20g, Scolopendra 3-6 bar, Scorpio 3-10g, Nidus Vespae 3-20g, Fructus Arctii 6-20g, Fructus Tribuli 6-35g;
The raw material components of medicine for external use and weight proportion are: Caulis Lonicerae 9-35g, Nidus Vespae 5-35g, Cortex Dictamni 6-35g, Bombyx Batryticatus 5-35g, Herba Ephedrae 3-15g, Radix Saposhnikoviae 5-35g, Semen Sinapis Albae 3-30g, Rhizoma Arisaematis 3-60g, Rhizoma Pinelliae 3-60g, quicklime 50-200g, Knoxia valerianoides 5-95g.
2, the psoriatic Chinese medicine composition of treatment according to claim 1, it is characterized in that the raw material components of described oral medicine and weight proportion are: Rhizoma Smilacis Glabrae 30g, Radix Sophorae Flavescentis 15g, Fructus Kochiae 15g, Flos Lonicerae 40g, Fructus Forsythiae 15g, Radix Saposhnikoviae 10g, Cortex Dictamni 30g, Radix Rehmanniae 30g, Bai Acorns root 50g, Radix Salviae Miltiorrhizae 15g, Caulis Spatholobi 15g, Radix Angelicae Sinensis 15g, Zaocys 10g, 2 of Scolopendras, Scorpio 5g, Nidus Vespae 10g, Fructus Arctii 15g, Fructus Tribuli 30g;
The raw material components of described medicine for external use and weight proportion are: Caulis Lonicerae 30g, Nidus Vespae 30g, Cortex Dictamni 30g, Bombyx Batryticatus 30g, Herba Ephedrae 12g, Radix Saposhnikoviae 30g, Semen Sinapis Albae 25g, Rhizoma Arisaematis 55g, Rhizoma Pinelliae 55g, quicklime 160g, Knoxia valerianoides 90g.Wear into fine powder, add Oleum Sesami and mix well.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100313636A CN101279054B (en) | 2008-05-22 | 2008-05-22 | Chinese medicinal composition for treating psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100313636A CN101279054B (en) | 2008-05-22 | 2008-05-22 | Chinese medicinal composition for treating psoriasis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101279054A true CN101279054A (en) | 2008-10-08 |
CN101279054B CN101279054B (en) | 2010-12-22 |
Family
ID=40011842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100313636A Expired - Fee Related CN101279054B (en) | 2008-05-22 | 2008-05-22 | Chinese medicinal composition for treating psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101279054B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474395A (en) * | 2014-11-29 | 2015-04-01 | 全椒贡菊园茶厂 | Traditional Chinese medicine for treating psoriasis |
CN105194469A (en) * | 2015-11-11 | 2015-12-30 | 尹柱良 | Traditional Chinese medicine oral liquid for treating psoriasis and preparation method |
CN105687965A (en) * | 2016-04-23 | 2016-06-22 | 汪琴 | Traditional Chinese medicine for treating psoriatic arthritis |
CN105797091A (en) * | 2015-11-25 | 2016-07-27 | 魏晓文 | Sweat-balancing treatment method for psoriasis |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104306833B (en) * | 2014-11-20 | 2018-05-01 | 韩文智 | A kind of Chinese medicine composition for treating psoriasis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1054528C (en) * | 1996-03-26 | 2000-07-19 | 苏新发 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
CN100534488C (en) * | 2004-10-25 | 2009-09-02 | 谢庚安 | Traditional Chinese medicinal powder for treating psoriasis |
-
2008
- 2008-05-22 CN CN2008100313636A patent/CN101279054B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474395A (en) * | 2014-11-29 | 2015-04-01 | 全椒贡菊园茶厂 | Traditional Chinese medicine for treating psoriasis |
CN105194469A (en) * | 2015-11-11 | 2015-12-30 | 尹柱良 | Traditional Chinese medicine oral liquid for treating psoriasis and preparation method |
CN105797091A (en) * | 2015-11-25 | 2016-07-27 | 魏晓文 | Sweat-balancing treatment method for psoriasis |
CN105687965A (en) * | 2016-04-23 | 2016-06-22 | 汪琴 | Traditional Chinese medicine for treating psoriatic arthritis |
Also Published As
Publication number | Publication date |
---|---|
CN101279054B (en) | 2010-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101130030B (en) | Medicine composition for treating nephropathy and uses of the same | |
CN103463528A (en) | Traditional Chinese medicine composition for treating chronic eczema | |
CN102526318A (en) | Chinese medicinal composition for preventing and treating chicken diseases and preparation method thereof | |
CN101279054B (en) | Chinese medicinal composition for treating psoriasis | |
CN101433650B (en) | Chinese medicinal composition for treating intermenstrual flow and dysmenorrhea | |
CN100589838C (en) | Acne treating Chinese herbal medicine preparation | |
CN101496874A (en) | Medicament for treating psoriasis and preparation method thereof | |
CN102309653A (en) | Traditional Chinese medicine (TCM) prescription for treating advanced menstruation (blood deficiency) | |
CN102309601A (en) | Traditional Chinese medicine (TCM) prescription for treating chloasma | |
CN102302622A (en) | Traditional Chinese medicine used for treating radiodermatitis | |
CN102579917B (en) | Traditional Chinese medicine for treating psoriasis | |
CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
CN101623413A (en) | Chinese medicinal composition for treating women mastitis | |
CN102671160A (en) | Traditional Chinese medicine decoction for treating edema and preparation method of traditional Chinese medicine decoction | |
CN101716296A (en) | Traditional Chinese medicine pill for treating psoriasis | |
CN102343031A (en) | Chinese medicinal composition for treating osteomyelitis | |
CN102225118A (en) | Blood-activating wind-dispelling liquid | |
CN101239140A (en) | Chinese medicine for treating psoriasis | |
CN101095810B (en) | Decoction medicine for treating seborrhoeic dermatitis and method for preparing the same | |
CN104873802A (en) | Traditional Chinese medicine composition for treating nephropyelitis | |
CN102920816A (en) | Traditional Chinese medicine formula for treating skin carbuncle due to heat-toxin congestion | |
CN103127414B (en) | Drug for treatment of chronic nephritis and early stage renal failure | |
CN103768160A (en) | Traditional Chinese medicinal prescription for treating postpartum urinary retention | |
CN101810745B (en) | Plaster for treating hyperplasia of mammary glands | |
CN102309654A (en) | Traditional Chinese medicine (TCM) prescription for treating spermatorrhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 Termination date: 20130522 |